| calcium channel, voltage-dependent, L type, alpha 1C subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
LACIDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.005449uM |
.004843uM |
View
|
| Sigma-2 Receptor |
BENZETHONIUM CHLORIDE |
Sigma2 |
84% |
.114uM |
.07uM |
View
|
| epidermal growth factor receptor |
TRIBROMSALAN |
Protein Tyrosine Kinase, EGF Receptor |
84% |
2.987uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NISOLDIPINE |
Calcium Channel Type L, Benzothiazepine |
84% |
.002484uM |
.002208uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
ASTEMIZOLE |
Serotonin 5-HT1B |
84% |
1.387uM |
.63uM |
View
|
| Cytochrom P450-1A2 monooxygenase |
NISOLDIPINE |
CYP450-1A2 Inhibition |
84% |
1uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
DISULFIRAM |
Adrenergic alpha2B |
84% |
3.218uM |
1.469uM |
View
|
| interleukin 8 receptor, beta |
DISULFIRAM |
Chemokine CXCR2 (IL-8B) |
84% |
6.013uM |
4.209uM |
View
|
| opioid receptor, kappa 1 |
DISULFIRAM |
Opiate kappa |
84% |
6.103uM |
2.441uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| phosphodiesterase 5A, cGMP-specific |
ZAPRINAST |
Phosphodiesterase PDE5 |
84% |
1.349uM |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
ZAPRINAST |
Phosphodiesterase PDE5 |
84% |
1.349uM |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
AURANOFIN |
Glucocorticoid |
84% |
1.317uM |
.599uM |
View
|
| cholinergic receptor, muscarinic 4 |
SULCONAZOLE |
Muscarinic M4 |
84% |
3.958uM |
.552uM |
View
|
| synaptic vesicle glycoprotein 2b |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
beta-Lactamase |
84% |
.0387uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
FLUNARIZINE |
Adrenergic alpha1D |
84% |
1.085uM |
.533uM |
View
|
| estrogen receptor 1 |
BISPHENOL A |
Estrogen ERalpha |
84% |
2.271uM |
.649uM |
View
|
| estrogen receptor 1 |
BISPHENOL A |
Estrogen ERalpha |
84% |
2.271uM |
.649uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
BETA-ESTRADIOL 3-BENZOATE |
Adrenergic, Norepinephrine Transporter |
84% |
17.229uM |
17.087uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
2-HYDROXYPROPYL-BETA-CYCLODEXTRIN |
Dopamine Transporter |
84% |
1.687uM |
1.341uM |
View
|
| cholinergic receptor, muscarinic 4 |
AMOXAPINE |
Muscarinic M4 |
84% |
1.737uM |
.242uM |
View
|
| monoamine oxidase A |
CHLOROXYLENOL |
Monoamine Oxidase MAOA |
84% |
1.829uM |
NoneNone |
View
|
| monoamine oxidase A |
CHLOROXYLENOL |
Monoamine Oxidase MAOA |
84% |
1.829uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
CLOTRIMAZOLE |
Adrenergic alpha1D |
84% |
15.012uM |
7.379uM |
View
|
| Protein-tyrosine kinase, Fyn |
AMIODARONE |
Protein Tyrosine Kinase, Fyn |
84% |
.817uM |
NoneNone |
View
|
| melanocortin 5 receptor |
AMIODARONE |
Melanocortin MC5 |
84% |
9.497uM |
8.909uM |
View
|
| A3 adenosine receptor |
TRETINOIN |
Adenosine A3 |
84% |
5.275uM |
2.982uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
TAMOXIFEN |
Serotonin 5-HT2B |
84% |
2.084uM |
1.326uM |
View
|
| matrix metallopeptidase 9 |
DACARBAZINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
84% |
.556uM |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
DACARBAZINE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
84% |
.556uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
CISAPRIDE |
Adrenergic alpha2A |
84% |
1.777uM |
.666uM |
View
|
| dopamine receptor D1A |
CLEMASTINE |
Dopamine D1 |
84% |
1.535uM |
.767uM |
View
|
| dopamine receptor D3 |
CISAPRIDE |
Dopamine D3 |
84% |
.144uM |
.049uM |
View
|
| prostaglandin-endoperoxide synthase 1 |
THIOGUANINE |
Cyclooxygenase COX-1 |
84% |
.601uM |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
THIOGUANINE |
Cyclooxygenase COX-1 |
84% |
.601uM |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
BENZBROMARONE |
Protein Serine/Threonine Kinase, ERK2 |
84% |
1.946uM |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
BENZBROMARONE |
Protein Serine/Threonine Kinase, ERK2 |
84% |
1.946uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
FLUOXETINE |
Adrenergic alpha2B |
84% |
1.528uM |
.698uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
FLUPHENAZINE |
Serotonin 5-HT1B |
84% |
1.912uM |
.869uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
LABETALOL |
Adrenergic alpha1D |
84% |
.521uM |
.256uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
R-(+)-PROPRANOLOL |
Serotonin 5-HT2B |
84% |
.438uM |
.279uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
GENTIAN VIOLET |
Adrenergic alpha1D |
84% |
1.98uM |
.973uM |
View
|
| adrenergic receptor, alpha 2b |
ISOTRETINOIN |
Adrenergic alpha2B |
84% |
6.612uM |
3.019uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
BROMOCRIPTINE |
CYP450-3A4 Inhibition |
84% |
2uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
GUANFACINE |
Serotonin 5-HT2C |
84% |
1.453uM |
.761uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
LYSERGOL |
Imidazoline I2, Central |
84% |
.607uM |
.405uM |
View
|
| adrenergic receptor, alpha 2a |
LYSERGOL |
Imidazoline I2, Central |
84% |
.607uM |
.405uM |
View
|
| Sigma-2 Receptor |
MEPAZINE |
Sigma2 |
84% |
.631uM |
.388uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
LEFLUNOMIDE |
Adrenergic, Norepinephrine Transporter |
84% |
4.63uM |
4.591uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
MITOTANE |
Adrenergic, Norepinephrine Transporter |
84% |
.819uM |
.812uM |
View
|
| dopamine receptor D3 |
TIAPRIDE |
Dopamine D3 |
84% |
1.149uM |
.39uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
ITRACONAZOLE |
CYP450-3A4 Inhibition |
84% |
.9uM |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
ROTENONE |
Serotonin 5-HT6 |
84% |
.87uM |
.404uM |
View
|
| adrenergic receptor, alpha 1b |
QUINACRINE |
Adrenergic alpha1B |
84% |
3.414uM |
1.89uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
NABUMETONE |
Adrenergic, Norepinephrine Transporter |
84% |
1.868uM |
1.853uM |
View
|
| cholinergic receptor, muscarinic 1 |
KETOTIFEN |
Muscarinic M1 |
84% |
1.112uM |
.268uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
NORTRIPTYLINE |
Dopamine Transporter |
84% |
1.678uM |
1.333uM |
View
|
| 5-hydroxytryptamine receptor 6 |
OXYMETAZOLINE |
Serotonin 5-HT6 |
84% |
1.67uM |
.775uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
OXYMETAZOLINE |
Calcium Channel Type L, Phenylalkylamine |
84% |
2.246uM |
2.184uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
BW-723C86 |
Serotonin 5-HT1B |
84% |
.4211uM |
.4001uM |
View
|
| A3 adenosine receptor |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Adenosine A3 |
84% |
.9891uM |
.559uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
CINNARIZINE |
Serotonin Transporter |
84% |
1.09uM |
.579uM |
View
|
| adrenergic receptor, alpha 2a |
HYDROXYCHLOROQUINE |
Imidazoline I2, Central |
84% |
.479uM |
.319uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
HYDROXYCHLOROQUINE |
Imidazoline I2, Central |
84% |
.479uM |
.319uM |
View
|
| Cytochrom P450-2D6 monooxygenase |
NORTRIPTYLINE |
CYP450-2D6 Inhibition |
84% |
1uM |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
OXICONAZOLE |
CYP450-2C9 Inhibition |
84% |
3uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
OXICONAZOLE |
CYP450-2C9 Inhibition |
84% |
3uM |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
LACIDIPINE |
CYP450-2C19 Inhibition |
84% |
2uM |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
SERTRALINE |
CYP450-2C19 Inhibition |
84% |
1uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
BITHIONOL |
Serotonin 5-HT2B |
84% |
6.789uM |
4.32uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
CYP450-2C9 Inhibition |
84% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
CYP450-2C9 Inhibition |
84% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
METHYLERGONOVINE |
Dopamine D1 |
84% |
1.077uM |
.539uM |
View
|
| dopamine receptor 2 |
METHYLERGONOVINE |
Dopamine D2L |
84% |
.829uM |
.276uM |
View
|
| adrenergic receptor, alpha 2a |
CYCLIZINE |
Adrenergic alpha2A |
84% |
1.551uM |
.582uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
BROMHEXINE |
Serotonin Transporter |
84% |
2.091uM |
1.111uM |
View
|
| opioid receptor, sigma 1 |
BENZTROPINE |
Sigma1 |
84% |
.139uM |
.059uM |
View
|
| histamine receptor H 2 |
MAPROTILINE |
Histamine H2 |
84% |
.4uM |
.393uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
MAPROTILINE |
Calcium Channel Type L, Benzothiazepine |
84% |
3.286uM |
2.921uM |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
DIHYDROERGOCRISTINE MESYLATE |
CYP450-3A4 Inhibition |
84% |
3uM |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
NITRENDIPINE |
CYP450-2C19 Inhibition |
84% |
3uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
TERCONAZOLE |
Dopamine Transporter |
84% |
5.472uM |
4.347uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
PENTAMIDINE |
Serotonin 5-HT2A |
84% |
1.639uM |
.468uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
PROCHLORPERAZINE |
Serotonin Transporter |
84% |
1.169uM |
.621uM |
View
|
| adrenergic receptor, alpha 2a |
PIPAMAZINE |
Imidazoline I2, Central |
84% |
.768uM |
.512uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
PIPAMAZINE |
Imidazoline I2, Central |
84% |
.768uM |
.512uM |
View
|
| monoamine oxidase A |
GUANABENZ |
Monoamine Oxidase MAOA |
84% |
1.787uM |
NoneNone |
View
|
| monoamine oxidase A |
GUANABENZ |
Monoamine Oxidase MAOA |
84% |
1.787uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
PIPAMAZINE |
CYP450-2D6 Inhibition |
84% |
.1uM |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
ECONAZOLE |
CYP450-2D6 Inhibition |
84% |
.4uM |
NoneNone |
View
|
| thromboxane A synthase 1 |
ECONAZOLE |
Thromboxane Synthetase |
84% |
.029uM |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
ECONAZOLE |
Thromboxane Synthetase |
84% |
.029uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DEXCHLORPHENIRAMINE |
Calcium Channel Type L, Benzothiazepine |
84% |
6.131uM |
5.45uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
RESERPINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.05uM |
1.993uM |
View
|
| adrenergic receptor, alpha 2a |
OLANZAPINE |
Imidazoline I2, Central |
83% |
1.158uM |
.772uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
OLANZAPINE |
Imidazoline I2, Central |
83% |
1.158uM |
.772uM |
View
|
| cholinergic receptor, muscarinic 5 |
OXYMETAZOLINE |
Muscarinic M5 |
83% |
1.332uM |
.957uM |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
EBASTINE |
Protein Tyrosine Kinase, HER2 Receptor |
83% |
1.0575uM |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
EBASTINE |
Protein Tyrosine Kinase, HER2 Receptor |
83% |
1.0575uM |
NoneNone |
View
|
| histamine receptor H 2 |
EBASTINE |
Histamine H2 |
83% |
2.9157uM |
2.8671uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
PROMETHAZINE |
Serotonin 5-HT1A |
83% |
2.596uM |
1.484uM |
View
|
| histamine receptor H 1 |
CHLORDIAZEPOXIDE |
Histamine H1, Central |
83% |
1.795uM |
.208uM |
View
|
| opioid receptor, sigma 1 |
PROMETHAZINE |
Sigma1 |
83% |
.287uM |
.12uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CANDESARTAN |
Adrenergic, Norepinephrine Transporter |
83% |
3.0652uM |
3.0398uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
METHAPYRILENE |
Adrenergic, Norepinephrine Transporter |
83% |
1.391uM |
1.38uM |
View
|
| mitogen activated protein kinase 3 |
CISPLATIN |
Protein Serine/Threonine Kinase, ERK1 |
83% |
4.624uM |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
CISPLATIN |
Protein Serine/Threonine Kinase, ERK1 |
83% |
4.624uM |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
CISPLATIN |
Protein Tyrosine Kinase, Fyn |
83% |
4.773uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
MEPAZINE |
Adrenergic, Norepinephrine Transporter |
83% |
1.877uM |
1.861uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE |
CYP450-2C9 Inhibition |
83% |
2uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
4-(PHENYLMETHYL)-1-[2-(TRIFLUOROMETHYL)BENZOYL]-PIPERIDINE |
CYP450-2C9 Inhibition |
83% |
2uM |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
MITOTANE |
Serotonin 5-HT6 |
83% |
1.402uM |
.651uM |
View
|
| melanocortin 3 receptor |
L-744832 |
Melanocortin MC3 |
83% |
3.395uM |
2.963uM |
View
|
| melanocortin 3 receptor |
L-744832 |
Melanocortin MC3 |
83% |
3.395uM |
2.963uM |
View
|
| adrenergic receptor, alpha 2a |
QUINACRINE |
Adrenergic alpha2A |
83% |
2.28uM |
.855uM |
View
|
| dopamine receptor D3 |
KETOTIFEN |
Dopamine D3 |
83% |
1.963uM |
.667uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
BOPINDOLOL |
Serotonin 5-HT2A |
83% |
1.581uM |
.452uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
SERTRALINE |
Calcium Channel Type L, Phenylalkylamine |
83% |
2.1436uM |
2.0841uM |
View
|